For further information please contact:
Seasoned leadership team poised to deliver clinical and commercial success
Former CEO of Phagenesis (Affiliated with Nestlé Health Science1), and VC at HBM Partners, Dresdner Kleinwort Benson and MVM.
Former Managing Director in Credit Suisse & Deutsche Bank.
Over 30 years of experience in financial services including investment banking, asset management and as a Chartered Accountant.
Held executive positions in regulatory affairs, quality assurance, and clinical operations in large pharmaceutical companies (Pfizer, Roche, AstraZeneca, Abbott) and start up biotech companies (Ocera, Gensia, Ancile).
Professor of Hepatology and Head of the Liver Failure Group at University College London and consultant hepatologist at the Royal Free Hospital in London.
Dr. Shapiro served as the Chief Medical Officer and Executive Vice-President of Research and Development during his time with Intercept Pharmaceuticals Inc. from 2007 to 2019
Expert in clinical trials, biostatistics, & regulatory affairs, representing clients for over 40 years, leading to 70 FDA product approvals.
